Rehaler A/S today announces the appointment of Henrik Olsen as its new CEO.
He will replace co-founder Troels Johansen, who will continue in the company as CTO and a vital member of the management team, focusing on bringing our Rehaler product through clinical trials as well as ensuring progress of our R&D portfolio and manufacturing.
Henrik Olsen brings 27+ years of experience within Medtech to the position, having worked previously as CEO in Vigmed AB (publ) and earlier held VP positions within Business Development, Marketing and Sales in Coloplast A/S.
“We’re confident that Henrik Olsen can guide this company into the future. With Henrik’s vast international experience within medtech and particular his commercial experience from both large cap and small cap, Henrik has a strong mix of competencies needed to take Rehaler into the commercial phase” said Thomas Feldthus, Chairman of the Board.
Henrik Olsen initiated the transition into the CEO role on June 15th, and will assume full responsibility before the end of June.